$CVM News

CEL-SCI Q2 EPS $(0.67) Down From $(0.08) YoY

CEL-SCI Announces Closing of Public Offering

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Signs Strategic Partnership, Distribution, And Revenue Sharing Agreement With Amarox For Regulatory Affairs, Marketing And Potential Commercialization Of Multikine In Treatment Of Head And Neck Cancer In Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Q4 2025 EPS $(0.68) Vs $(3.25) Q4 2024

Cel-Sci: Fiscal Q1 Earnings Snapshot

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference

CEL-SCI Announces Closing of $10 Million Public Offering

CEL-SCI shares are trading lower after the company announced a $10 million public offering.

Why Is CEL-SCI Stock Crashing After-Hours?

CEL-SCI Announces Pricing of $10 Million Public Offering

Reported Earlier, CEL-SCI Prices $10M Public Offering Of 1,111,200 Common Shares At $9.00 Each To Fund Multikine Development

CEL-SCI Announces Proposed Public Offering

CEL-SCI Announces Proposed Public Offering; No Size Or Amount Disclosed

CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results

Cel-Sci: Fiscal Q3 Earnings Snapshot